Medlive Technology Co., Ltd. announced a planned change of auditor, confirming that Ernst & Young will retire at the conclusion of the 15 May 2026 annual general meeting. The decision follows the parties’ inability to agree on the audit fee for the financial year ending 31 December 2026.

The board, acting on the Audit Committee’s recommendation, has resolved to propose Deloitte Touche Tohmatsu as the new auditor for the period from the close of the 2026 AGM until the next annual general meeting. Shareholder approval will be sought in May 2026.

In selecting Deloitte, the Audit Committee evaluated the firm’s audit plan, timetable, partner involvement, market reputation, industry knowledge, technical competence, and fee proposal relative to Medlive’s size, complexity, and risk profile. Deloitte was deemed independent, capable, and in the best interests of both the Company and its shareholders.

Ernst & Young confirmed that no matters need to be brought to shareholder attention in connection with its retirement, and the Board reported no disagreements or other issues related to the change.

Medlive will circulate a detailed AGM notice, proxy form, and the proposal for Deloitte’s appointment to shareholders in due course.